The use of perianal methylene blue injection on post-haemorrhoidectomy pai

Not Applicable

Completed

• Conditions: Symptomatic 3rd and 4th degree haemorrhoids; Circulatory System; Haemorrhoids

• Registration Number: ISRCTN69637260
• Lead Sponsor: Khoo Teck Puat Hospital (Singapore)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-07-11
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1. Fresh cases of symptomatic 3rd and 4th degree haemorrhoids
2. Aged between 21 and 80 years of age
3. Able to give informed consent

Exclusion Criteria

1. Undergoing combined procedures for fissures or fistulae
2. Do not give informed consent
3. Allergy reactions to diclofenac, Daflon®, Fybogel®, methylene blue, paracetamol
4. Pregnant or breast feeding women

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Pain, assessed using a 11-point visual analogue pain score from 0 to 10 (0 = no pain; 10 = unbearable pain). Participants will be asked to record their maximum pain score daily before retiring. <br>2. Total number of analgesics tablets patients have taken for the day

Secondary Outcome Measures

Name	Time	Method
Complications which include: <br>1. Pain requiring unscheduled stay or unscheduled return<br>2. Urinary retention<br>3. Delayed bleeding<br>4. Discharge<br>5. Itching<br>6. Skin reaction to methylene blue